Ingevity Corp buy BMO Capital Markets
Start price
05.09.25
/
50%
€51.00
Target price
05.09.26
€58.30
Performance (%)
30.39%
Price
19.08.26
?
Summary
This prediction is currently active. With a performance of 30.39% the BUY prediction by BMO_Capital_Markets is a big success. This prediction currently runs until 05.09.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ingevity Corp | -3.704% | -3.704% |
| iShares Core DAX® | -0.874% | 5.325% |
| iShares Nasdaq 100 | -0.381% | 1.979% |
| iShares Nikkei 225® | -1.676% | 1.952% |
| iShares S&P 500 | -0.655% | 2.069% |
Comments by BMO_Capital_Markets for this prediction
In the thread Ingevity Corp diskutieren
Ingevity (NYSE:NGVT) had its price target raised by analysts at BMO Capital Markets from $62.00 to $68.00. They now have an "outperform" rating on the stock.
Ratings data for NGVT provided by MarketBeat